Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Literature
1.
Berthold HK, Unverdorben S, Zitterman A, Degenhardt R, Baumeister B, Unverdorben M, Krone W, Vetter H, Gouni-Berthold I (2004) Age-dependant effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women. Osteoporos Int 15(6):459–467CrossRef
2.
Bagger YZ, Tanko LB, Alexandersen P, Ravn P, Christiansen C (2003) Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal. Bone 33(3):301–307CrossRef
3.
Kimmel DB (1991) Quantitative histological changes in proximal tibial growth cartilage in aged female rats. Cells Materials [Suppl 1]:11–18
4.
Hannon R, Blumsohn A, Naylor K, Eastell R (1998). Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res 13:1124–1133
5.
Garnero P, Borel O, Delmas D (2001). Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type-I collagen in osteoporosis. Clin Chem 47:694–702
6.
Hatano H, Maruo A, Bolander M, Sarkar G (2003). Statin stimulates bone morphogenetic protein-2, aggregan and type-2 collagen gene expression and proteoglycan synthesis in rat chondrocytes. J Orthop Sci 2(6):842–848CrossRef
Metadata
Title
Effect of atorvastatin on markers of bone turnover
Authors
Alan J. Martin
M. Casey
M. Healy
J. B. Walsh
Publication date
01-04-2005
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 4/2005
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-004-1824-x

Other articles of this Issue 4/2005

Osteoporosis International 4/2005 Go to the issue

Opinion Paper

The need for microsimulation to evaluate osteoporosis interventions

Original Article

Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women

Original Article

Epidemiology of fractures in people with severe and profound developmental disabilities

Original Article

A study of bone mineral density in women with forearm fracture in Northern Ireland

Original Article

Bone mineral mass in males and females with and without Down syndrome

Original Article

Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures